Europe Wearable Injectors Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (On-Body Injectors, Off-Body Injectors); Application (Diabetes, Oncology, Cardiovascular Disease, Autoimmune Disease, Other Applications); End User (Hospitals and Clinics, Homecare Setting, Other End User), and Country

No. of Pages: 117    |    Report Code: TIPRE00013296    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Wearable Injectors Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Global Wearable Injectors Market – By Type

1.3.2        Global Wearable Injectors Market – By Application

1.3.3        Global Wearable Injectors Market – By End User

1.3.4        Global Wearable Injectors Market – By Geography

2.           Europe Wearable Injectors Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Wearable Injectors Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Wearable Injectors Market - Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Wearable Injectors Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Chronic Diseases Prevalence

5.1.2        Technological Advancements and Design Development

5.1.3        Conventional Drug Delivery System Limitations

5.2         Market Restraints

5.2.1        Preference Of Alternative Drug Delivery

5.3         Market Opportunities

5.3.1        Increasing Demand for Biologics

5.4         Future Trends

5.4.1        Integration of Wearable Injectors During Early Drug Development

5.5         Impact Analysis

6.           Wearable Injectors Market – Europe Analysis

6.1         Europe Wearable Injectors Market Revenue Forecasts and Analysis

7.         Europe Wearable Injectors Market Analysis And Forecasts To 2027 – By Type

7.1         Overview

7.2         Europe Wearable Injectors market, By Type 20110 & 2027 (%)

7.2.1        Europe Wearable Injectors Market Revenue and Forecasts to 2027, By Type (US$ Mn)

7.3         On-Body Injectors

7.3.1        Overview

7.3.2        Europe On-Body Injectors Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Off-Body Injectors

7.4.1        Overview         

7.4.2        Europe Off-Body Injectors Market Revenue and Forecasts to 2027 (US$ Mn)

Europe Wearable Injectors Market Analysis –  By Application

8.1         Overview

8.2         Europe Wearable Injectors Market, By Application 20110-2027 (%)

8.2.1        Europe Wearable Injectors Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3         Diabetes

8.3.1        Overview

8.3.2        Europe Diabetes Market Revenue and Forecasts to 2027 (US$ Mn)

8.4         Oncology

8.4.1        Overview

8.4.2        Europe Oncology Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Cardiovascular Disease

8.5.1        Overview

8.5.2        Europe Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Autoimmune Disease

8.6.1        Overview

8.6.2        Europe Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Other Applications

8.7.1        Overview

8.7.2        Europe Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Europe Wearable Injectors Market Analysis –  By End User

9.1         Overview

9.2         Europe Wearable Injectors Market, By End User 2019-2027 (%)

9.2.1        Europe Wearable Injectors Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Europe Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

9.4         Homecare Setting

9.4.1        Overview

9.4.2        Europe Homecare Setting Market Revenue and Forecasts to 2027 (US$ Mn)

9.5         Other End User

9.5.1        Overview

9.5.2        Europe Other End User Market Revenue and Forecasts to 2027 (US$ Mn)

 

10.        Wearable Injectors Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1      Europe Wearable Injectors Market Revenue and Forecasts To 2027...........................

10.2.1     Overview

10.2.2     Europe: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)

10.2.3     Europe Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.4     Europe Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.5     Europe Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.6     Europe: Wearable Injectors Market, by Country, 2019 & 2027 (%)

10.2.7     Germany: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.1       Germany: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.2       Germany Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.7.3       Germany Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.7.4       Germany Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.8     UK: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.1       UK: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.2       UK Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.8.3       UK Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.8.4       UK Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.9     France: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.1       France: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.2       France Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.9.3       France Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.9.4       France Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.10  Spain: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.1    Spain: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.2    Spain Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.10.3    Spain Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.10.4    Spain Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.11  Italy: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.1    Italy: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.2    Italy Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.11.3    Italy Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.2.11.4    Italy Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on Europe Wearable Injectors Market

11.1      Europe: Impact Assessment of COVID-19 Pandemic

12.        Wearable Injectors Market –Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market, (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      BD

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      CeQur SA

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Debiotech S.A.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      E3D Elcam Drug Delivery Devices

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Insulet Corporation

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Gerresheimer AG

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Tandem Diabetes Care Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Zealand Pharma A/S

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      West Pharmaceutical Services, Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Ypsomed AG

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

13.11   Medtronic

13.11.1  Key Facts

13.11.2  Business Description

13.11.3  Products and Services

13.11.4  Financial Overview

13.11.5  SWOT Analysis

13.11.6  Key Developments

13.13   Amgen, Inc.

13.13.1  Key Facts

13.13.2  Business Description

13.13.3  Products and Services

13.13.4  Financial Overview

13.13.5  SWOT Analysis

13.13.6  Key Developments                                      

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             Europe Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 3.             Europe Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.             Germany Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             Germany Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 6.             Germany Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             UK Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             UK Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 9.             UK Wearable Injectors Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 10.          France Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          France Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 12.          France Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Spain Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Spain Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 15.          Spain Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Italy Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17.          Italy Wearable Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 18.          Italy Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19.          List of Abbreviation                                                                

LIST OF FIGURES

Figure 1.           Wearable Injectors Market Segmentation

Figure 2.           Europe Wearable Injectors Market Overview

Figure 3.          Europe: Wearable Injectors Market, by Key Country – Revenue (2019) (USD Million)

Figure 4.          Europe Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)

Figure 5.          Europe: Wearable Injectors Market, by Country, 2019 & 2027 (%)

Figure 6.          Germany: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 7.          UK: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 8.          France: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 9.          Spain: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 10.        Italy: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 11.         Impact of Covid-19 Pandemic In North American Country Markets

 

The List of Companies - Europe Wearable Injectors Market

  1. BD
  2. CeQur SA
  3. Debiotech S.A
  4. E3D Elcam Drug Delivery Devices
  5. Insulet Corporation
  6. Gerresheimer AG
  7. Tandem Diabetes Care Inc
  8. Zealand Pharma A/S
  9. West Pharmaceutical Services, Inc
  10. Ypsomed AG
  11. Medtronic
  12. Amgen, Inc